15

Fip Icon

People-Centred Care

People-Centred Care icon Arch
Icon 1

FIP Development Goal 15 Education & Workforce Element 

Globally, we will have: 

Strategies in place to develop pharmaceutical education and the workforce to support the delivery of people-centred care in practice.

Mechanisms

  • Ensure academic capacity infrastructures in place to develop people-centred-care knowledge and skills in initial education and training (FIP Development Goal 1 [w]), including in interprofessional education development (FIP Development Goal 8 [w]).
  • Embed people-centred care as a strategic outcome in earlier career training (FIP Development Goal 2 [w]) as well as throughout advanced and expert specialist development (FIP Development Goal 4 [w]).
  • Utilise people-centred care as an indicator for evaluating and developing quality assurance in education (FIP Development Goal 3 [w]), as well as for monitoring workforce impact (FIP Development Goal 11 [w]).
  • Develop competency frameworks across all stages of workforce development with people-centred care at the core (FIP Development Goal 5 [w]).
Icon 1

FIP Development Goal 15 Practice Element 

Globally, we will have: 

Collaborative interprofessional strategies and people-centred professional services to support the prevention, screening, clinical management and therapeutic optimisation of non-communicable diseases (NCDs) and long-terms conditions (LTCs) including cardiovascular diseases, chronic respiratory conditions (such as asthma and chronic obstructive pulmonary disease, COPD), diabetes, cancer, mental health conditions, dermatological conditions and others.

Mechanisms

  • Develop and implement structured and evidence-based disease prevention (and secondary prevention) strategies and professional services for NCDs and LTCs, that effectively address and modify or minimise risk factors.
  • Develop and implement structured and evidence-based strategies and professional services for community-based screening and monitoring of NCDs and LTCs and their risk factors, symptoms and clinical signs through point-of care tests and other assessment methods like structured tools and questionnaires to identify individuals that may require further diagnostics and/or care.
  • Develop and implement structured systems and protocols for the referral of potential patients to other HealthCare Professionals, and for sharing clinical findings from patient screening and monitoring across the health care team and system, namely via shared access (for consultation and input) to the patient’s (electronic) health records.
  • Develop and implement structured and evidence-based strategies and professional services for the optimisation of treatments and medicines use, to ensure optimal clinical and quality of life outcomes and resource utilisation.
  • Develop and implement structured and evidence-based strategies and professional services for special patient populations with long-term conditions and specific needs, such as older adults, people with functional diversity, rare disease patients, poor and vulnerable patients, illiterate patients, migrant populations, refugees and other groups.
Icon 1

FIP Development Goal 15 Science Element 

Globally, we will have: 

Capacity to monitor and understand health-related characteristics leading to innovative personalized approaches for improved people-centred care.

Mechanisms

  • Promote provision of science-based medicine information.
  • Collaborate with stakeholder to make available the latest relevant scientific information.
  • Support development of new medical products to meet healthcare needs.
  • Collaborate with global (the World Health Organization) and regional stakeholders to develop strategies for repurposing of licensed medicines for other conditions.
Medicines reconciliation: A toolkit for pharmacists (2021) Thumbnail

Medicines reconciliation: A toolkit for pharmacists (2021)

Read Publication
Cold, flu and sinusitis: Managing symptoms and supporting self-care — A handbook for pharmacists (2021) Thumbnail

Cold, flu and sinusitis: Managing symptoms and supporting self-care — A handbook for pharmacists (2021)

Read Publication
Diabetes prevention, screening and management: A handbook for pharmacists (2021) Thumbnail

Diabetes prevention, screening and management: A handbook for pharmacists (2021)

Read Publication
Nutrition and weight management services: A toolkit for pharmacists (2021) Thumbnail

Nutrition and weight management services: A toolkit for pharmacists (2021)

Read Publication
Community pharmacists have a crucial role to play in responsible over-the-counter pain management (2021) Thumbnail

Community pharmacists have a crucial role to play in responsible over-the-counter pain management (2021)

Read Publication
Joint statement on Patient Solidarity Day (2021)  Thumbnail

Joint statement on Patient Solidarity Day (2021) 

Read Publication
Community Pharmacy at a Glance 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021) Thumbnail

Community Pharmacy at a Glance 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021)

Read Publication
Community Pharmacy Global Report 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021) Thumbnail

Community Pharmacy Global Report 2021: Regulation, scope of practice, remuneration, and distribution of medicines through community pharmacy premises and other outlets (2021)

Read Publication
Medicines use review: A toolkit for pharmacists (2020) Thumbnail

Medicines use review: A toolkit for pharmacists (2020)

Read Publication
FIP Position Statement: Emerging technologies and pharmacy practice (2020) Thumbnail

FIP Position Statement: Emerging technologies and pharmacy practice (2020)

Read Publication
Patient Safety: Pharmacists’ role in “Medication without harm” (2020) Thumbnail

Patient Safety: Pharmacists’ role in “Medication without harm” (2020)

Read Publication
FIP Regional Conference for the European Region - Delivering primary health care: Pharmacists taking the next leap forward (2020) Thumbnail

FIP Regional Conference for the European Region - Delivering primary health care: Pharmacists taking the next leap forward (2020)

Read Publication
FIP Statement of Policy: Sustainability of pharmacist-delivered professional services through viable remuneration models (2020) Thumbnail

FIP Statement of Policy: Sustainability of pharmacist-delivered professional services through viable remuneration models (2020)

Read Publication
COVID-19 Summary Guidance #9: Notice to community pharmacy patients and customers (2020) Thumbnail

COVID-19 Summary Guidance #9: Notice to community pharmacy patients and customers (2020)

Read Publication
Joint Statement of Policy by the International Pharmaceutical Federation (FIP) and the Global Self-Care Federation (GSCF) on Responsible and Effective Self-care (2019) Thumbnail

Joint Statement of Policy by the International Pharmaceutical Federation (FIP) and the Global Self-Care Federation (GSCF) on Responsible and Effective Self-care (2019)

Read Publication
FIP Statement of Policy: The role of pharmacists in non-communicable diseases (2019) Thumbnail

FIP Statement of Policy: The role of pharmacists in non-communicable diseases (2019)

Read Publication
Beating non-communicable diseases in the community: The contribution of pharmacists (2019) Thumbnail

Beating non-communicable diseases in the community: The contribution of pharmacists (2019)

Read Publication
FIP Statement of Policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution (2018) Thumbnail

FIP Statement of Policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution (2018)

Read Publication
140th WHO Executive Board: Intervention on provisional agenda item 10.2 ─ Draft global action plan on the public health response to dementia (2017) Thumbnail

140th WHO Executive Board: Intervention on provisional agenda item 10.2 ─ Draft global action plan on the public health response to dementia (2017)

Read Publication

Shaping the future of self-care through pharmacy

Shaping the future of self-care through pharmacy Thumbnail

As healthcare providers, pharmacists have an important role to play in supporting self-care.  FIP is launching a new 17 event digital programme: ‘Shaping the future of self-care through pharmacy”’. The programme is composed of 8 episodes that will focus on accelerating UHC for all by enabling self-care through community pharmacy.  Additionally, nine episodes will focus on self-care support for community pharmacy teams.

More on the programme events

Pharmacy cares: Supporting patients with non-communicable diseases

Pharmacy cares: Supporting patients with non-communicable diseases Thumbnail

Pharmacists have a crucial role to play in the prevention, screening, management and treatment optimisation of non-communicable diseases. FIP is launching an extensive programme of digital events to support pharmacists in this area.. The programme will consist of various series of events focusing on topics such as diabetes care and management, optimising the use of medicines and patient safety, pharmacists’ role in healthy nutrition and weight management, pain management, cancer care and anticoagulation treatment management.

More on the programme events

FIP “Setting goals for the decade ahead” | Episode 8 | FIP DG 15: People-centred care

FIP “Setting goals for the decade ahead” | Episode 8 | FIP DG 15: People-centred care Thumbnail
July 7, 2021

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021.

Episode 8 of the FIP Development Goals Digital Programme has as a focus – people-centred care. The goal visualizes collaborative interprofessional strategies and people-centred professional services to support the prevention, screening, clinical management, and therapeutic optimisation of non-communicable diseases (NCDs) and long-terms conditions (LTCs). Hence, the event will seek to amplify how pharmaceutical education, workforce, practice and sciences can be integrated to ensure pharmacists’ contribution to the prevention and management of NCDs.

Learning objectives:
1. Describe and explain the components of FIP DG 15 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 15 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 15
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Watch video

FIP Global Summit on Primary Health Care: Pharmacists transforming vision into actions

FIP Global Summit on Primary Health Care: Pharmacists transforming vision into actions Thumbnail
October 25, 2021

On 25 October 2021, it will be the third anniversary of the World Health Organization’s Astana Declaration on Primary Health Care (PHC), for which FIP pledged its commitment to accelerate progress in strengthening PHC. In 2020, the WHO published its Operational Framework for PHC to translate the vision of the Astana Declaration into actions. To mark this date and showcase how pharmacists can utilise and contribute to the WHO operational framework, FIP is organizing the digital FIP Global Summit on Primary Health Care. The summit will host a high-level discussion with the WHO to explore the strategic levers needed for pharmacists to strengthen primary health care.

At the end of this session, participants will:

1. Learn about WHO’s operational framework on primary health care to translate vision into actions
2. Explore initiatives from FIP member organizations on primary health care
3. Engage in a high-level discussion on strategic priorities needed for pharmacists to strengthen primary health care

Watch video

Pharmaceutical care for people with hearing impairment or deaf

Pharmaceutical care for people with hearing impairment or deaf Thumbnail
September 29, 2021

This event will focus on the role that pharmacists can play in providing pharmaceutical care for people with hearing impairment or a disability linked to hearing loss. Pharmacists must provide clear messages and adapt their communication strategies to this particular population group to ensure optimal use of medicines and medical devices, and they need to have the knowledge and skills to do so. Also, people with hearing loss face different challenges and this problem becomes more relevant with age. Pharmacists can support patients in detecting early signs of hearing loss and taking the appropriate actions.

Watch video

Trusted for health: Pharmacy, Medication Adherence & Communication

Trusted for health: Pharmacy, Medication Adherence & Communication Thumbnail
September 29, 2021

Poor medication adherence has emerged as a major public health concern in the last decade, and pharmacists may play a vital role in medication adherence by implementing many of the solutions demonstrated at COVID-19.

FIP adapted the theme “Pharmacy: Always trusted for your health” for World Pharmacy Week; and expanding on that theme, FIP would like to welcome your attendance to this event. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1 to discuss the role of pharmacists in medication adherence and communication.
2 to share some regional and global thoughts on the common communication gaps and challenges that are experienced in all patient facing sectors
3 to highlight various regional and global strengths, accomplishments, and success stories in terms of medication adherence and communication in pharmacy.

Watch video

O papel do farmacêutico nas doenças não transmissíveis / The role of pharmacists in non-communicable diseases

O papel do farmacêutico nas doenças não transmissíveis / The role of pharmacists in non-communicable diseases Thumbnail
July 21, 2021
Watch video

Delivering asthma right care: For hospital pharmacists

Delivering asthma right care: For hospital pharmacists Thumbnail
July 15, 2021

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine that can result in waste and harm including avoidable hospital attendances and admissions. Hospital pharmacists can be an important part of the asthma pathway and powerful change agents. This webinar will provide updates on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from experts from the Asthma Right Care social movement about how to make impactful change happen in the provision of asthma care within secondary care settings.

By the end of this webinar participants will have:
1. Received a critical update on international asthma guidelines and the implications for hospital pharmacists
2. Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and acute care and how to use the right medicines in the right way
3. Discussed what leadership opportunities, motivation and capabilities are needed to bring about change such as improved discharge from emergency departments and respiratory wards; and shared approaches between hospital and community pharmacists.

Watch video

"Just Culture" approach to community pharmacy practice regulation - An overview

July 13, 2021

Many jurisdictions around the world have implemented Apology Legislation and non-punitive medication error reporting requirements in order to create transparency, learning and prevention to enhance patient confidence and patient safety in the healthcare system and work towards creating a Just Culture or a Culture of Safety in health professionals and practice sites.   This webinar will present the value and the experiences of jurisdictions, which have enacted legislation and additional standards of care, for community pharmacy practice. Spread and scale of learning through international collaboration exemplified by the international medical regulatory authority will also be presented.

Learning Objectives:

1)      The importance sections of the FIP #4757 (Pharmacists Role in Medication without Harm) and Culture of Safety.

2)      The value of Apology Legislation on medication error resolution, transparency and patient confidence.

3)      The value of centralised medication error reporting in community pharmacy practice to enhance patient safety, quality assurance and prevent errors.

4)      The importance of international collaboration for the evolution to “Just Culture” and supportive legislation.

Watch video

Delivering asthma right care: For community pharmacists

Delivering asthma right care: For community pharmacists Thumbnail
July 5, 2021

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine. Community pharmacy can be an important part of the asthma pathway and powerful change agents. This webinar will update on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from community pharmacists in the Asthma Right Care social movement about how to have impactful conversations about personal, national and international change and how to make it happen.

By the end of this webinar participants will have:
-Received a critical update on international asthma guidelines and the implications for pharmacists
-Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and how to use the right medicines in the right way
-Discussed what opportunities, motivation and capabilities are needed to bring about change.

Watch video

La farmacia humanitaria durante el covid-19. Gestión de desafíos durante una nueva era

La farmacia humanitaria durante el covid-19. Gestión de desafíos durante una nueva era Thumbnail
May 29, 2021

La farmacia humanitaria durante el covid-19. Gestión de desafíos durante una nueva era 

En este webinar discutiremos cómo diversas organizaciones humanitarias -FSF-Argentina, FSF-Chile y FSF-España- centradas en el trabajo de farmacia, se han adaptado a la pandemia de COVID-19.
Objetivos de aprendizaje:
1. Comprender cómo puede continuar el trabajo humanitario en tiempos de pandemia.
2. Conocer varios ejemplos de trabajo humanitario durante la pandemia de COVID-19.
3. Obtener nuevas ideas y construir redes dentro del campo de la farmacia humanitaria.

Los temas se basan en el  trabajo, incluyendo desafíos e innovaciones, que tres organizaciones (de España, Argentina y Chile) han desarrollado durante la pandemia de COVID-19

Watch video

Our work

The following FIP programmes of work and structures support the implementation of this Goal:

FIP Board of Pharmaceutical Practice and sections 

Non-communicable Diseases Programme

Prevention Programme

Primary Health Care Programme